Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
13.75
+0.46 (3.46%)
Aug 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.16 - 13.79
52 week 11.85 - 24.09
Open 13.35
Vol / Avg. 0.00/486,405.00
Mkt cap 737.25M
P/E     -
Div/yield     -
EPS -0.36
Shares 55.39M
Beta     -
Inst. own     -
Oct 20, 2014
Q3 2014 Novadaq Technologies Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Aug 14, 2014
Novadaq Technologies Inc at Canaccord Genuity Growth Conference
Aug 7, 2014
Novadaq Technologies Inc at Piper Jaffray Heartland Summit
Aug 5, 2014
Q2 2014 NOVADAQ TECHNOLOGIES INC Earnings Release
Aug 5, 2014
Q2 2014 Novadaq Technologies Inc Earnings Call
Jun 24, 2014
NOVADAQ TECHNOLOGIES INC at JMP Securities Healthcare Conference
Jun 18, 2014
Novadaq Technologies Inc at Bloom Burton & Co Healthcare Investor Conference
Jun 10, 2014
NOVADAQ TECHNOLOGIES INC at William Blair & Company LLC Growth Stock Conference
May 28, 2014
NOVADAQ TECHNOLOGIES INC at Craig-Hallum Institutional Investor Conference
More events from DailyFinance »    

Address

Suite 202, 5090 Explorer Drive
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. It manufactures SPY systems, FIREFLY hardware components, and PINPOINT Systems at its manufacturing facility located in Richmond British Columbia. The Company�s SPY imaging core technology platform provides clinically anatomic and physiologic images during a variety of complex surgical procedures. The SPY technology platform allows for the development of specific devices based on the needs of the surgeon and the specific application. In May 2014, the Company acquired Aimago SA, a privately held medical imaging company.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Stephen Purcell Chief Financial Officer
Bio & Compensation  - Reuters
Mary Kay Baggs Senior Vice President of Marketing
Bio & Compensation  - Reuters
Roger Deck Vice President - Operations
Bio & Compensation  - Reuters
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Age: 82
Bio & Compensation  - Reuters
G. Steven Burrill Independent Director
Age: 69
Bio & Compensation  - Reuters
Aaron Davidson Independent Director
Bio & Compensation  - Reuters
Harold O. Koch Jr. Independent Director
Bio & Compensation  - Reuters
William A. MacKinnon Independent Director
Age: 67
Bio & Compensation  - Reuters